Table 2.
Clinicopathological analysis and patient survival.
Pathological Findings | Comparison | Number (of Patients) | Median Survival (Months) | p-Value |
---|---|---|---|---|
Differentiation | Well: mod-poor | 081:155 | 21:17 | 0.0005 |
Invasion | ||||
…to bile duct (CH) | −ve: +ve | 133: 103 | 20:16 | 0.027 |
…to duodenum (DU) | −ve: +ve | 163: 073 | 21:13 | 0.005 |
…to front constructs of pancreas (S) | −ve: +ve | 127: 109 | 22:14 | 0.001 |
…to back constructs of pancreas (RP) | −ve: +ve | 078: 158 | 29:15 | ≤0.001 |
…to portal vein (PV) | −ve: +ve | 172: 064 | 22:11 | ≤0.001 |
…to artery (A) | −ve: + ve | 222: 014 | 19:09 | 0.003 |
…to peripancreatic neuroplexus (PL) | −ve: + ve | 167: 069 | 23:11 | ≤0.001 |
…to the other organs (OO) | −ve: + ve | 223: 013 | 18:12 | 0.011 |
…to lymph duct in the pancreas (Ly) | ≤1: ≥1 | 162:074 | 22:12 | ≤0.001 |
…to vein in the pancreas (V) | ≤1: ≥1 | 095: 141 | 27:14 | 0.002 |
…to nerve in the pancreas (Ne) | ≤1: ≥1 | 076: 160 | 29:15 | ≤0.001 |
…to main pancreatic duct (Mpd) | −ve: + ve | 124:112 | 21:16 | 0.317 |
Pathological findings including invasion to different parts of the pancreas were analyzed to determine median survival time (MST) and grades of PDAC. p ≤ 0.05 were considered significant.